HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 265-276 of 1,811
Drug study icon
CompletedNCT01010750

Utility of a Standardized Battery of Tests for ADHD

Official study title

A Phase I, Randomized, Double Blind, Three-Period Crossover, Estimation Study Using Lisdexamfetamine Dimesylate, Immediate Release Mixed Amphetamine Salts and Placebo to Evaluate the Utility of a Standardized Computer Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

In Houston
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Shire
Drug study icon
CompletedNCT01328756

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

What is this study about?

Researchers studied Lisdexamfetamine dimesylate, tracking side effects to assess safety and tolerability in children and adolescents with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Hoboken
ADHDMedication studyAges 6–17
Countries
United Kingdom, Belgium, Germany, + 7 others
Sponsor
Shire
Drug study icon
CompletedNCT01081145

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

What is this study about?

This study evaluated the safety and effectiveness of Extended-release Guanfacine Hydrochloride for people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
ADHDMedication studyAges 6–17
Countries
United States, France, Canada, + 7 others
Sponsor
Shire
Drug study icon
CompletedNCT02096952

Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD

Official study title

Open-Label Treatment Trial to Assess the Short-Term Tolerability, Safety, and Efficacy of Methylphenidate Hydrochloride Extended-Release Liquid Formulation in High-Functioning Autism Spectrum Disorder Adults With Attention-Deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Boston
ADHDMedication studyAges 18–40
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Behavioral study icon
CompletedNCT06012851

Mobile Behavioral Parent Training for Childhood ADHD: A Micro-study

Official study title

Personalizing Behavioral Parent Training: Improving Reach and Outcomes for Families of Children With Attention Deficit Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

In Buffalo
ADHDBehavioural studyAges 7–12
Countries
United States
Sponsor
Florida International University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.